Aristocort A

ANDA 88780, held by Astellas. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 88780 (Aristocort A), held by Astellas, was first approved by FDA on Oct 1, 1984, with 9 approved supplements and 0 published complete response letters.

First approved: Oct 1, 1984
Supplements approved: 9
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 10 submissions below

Date	Submission	Status	Documents
Oct 1, 1984	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Aristocort A0.1% · ointment;topical	Triamcinolone Acetonide	Discontinued

All 10 submissions, including labeling and manufacturing supplements


Jul 20, 1999	Supplement 6Manufacturing	Approved	None posted
Jul 20, 1999	Supplement 7Manufacturing	Approved	None posted
Jul 20, 1999	Supplement 8Manufacturing	Approved	None posted
Jul 20, 1999	Supplement 9Manufacturing	Approved	None posted
Nov 20, 1990	Supplement 2Manufacturing	Approved	None posted
Nov 20, 1990	Supplement 3Manufacturing	Approved	None posted
Nov 20, 1990	Supplement 5Labeling	Approved	None posted
Oct 13, 1989	Supplement 4Manufacturing	Approved	None posted
Oct 3, 1986	Supplement 1Manufacturing	Approved	None posted
Oct 1, 1984	Original application	Approved	None posted

Identifiers

Application: ANDA 88780
Drugs@FDA: Overview at FDA
Company: Astellas Pharma

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters